ASCEND ADVANCED THERAPIES LIMITED
Get an alert when ASCEND ADVANCED THERAPIES LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Cash
£23M
+775.4% vs 2022
Net assets
£39M
+1,005.3% vs 2022
Employees
94
+370% vs 2022
Profit before tax
-£30M
-263.3% vs 2022
Watchouts
Facts from the Companies House register and the latest accounts — not a rating
-
Annual accounts overdue
Due 2025-09-30.
-
3 officer resignations in last 12 months
Multiple officers have left the board recently — see the People section for who.
Net assets
2-year trend · vs Health Care median
Accounts
2-year trend · Δ = latest vs prior filed period · latest reflected 2023-12-31
| Metric | Trend | 2022-12-31 | 2023-12-31 | Δ vs prior |
|---|---|---|---|---|
| Turnover | — | £1,630,270 | — | |
| Operating profit | -£8,299,181 | -£30,648,665 | -269.3% | |
| Profit before tax | -£8,299,181 | -£30,154,720 | -263.3% | |
| Net profit | -£7,370,848 | -£29,102,611 | -294.8% | |
| Cash | £2,656,666 | £23,256,905 | +775.4% | |
| Total assets less current liabilities | £3,512,076 | £43,171,621 | +1,129.2% | |
| Net assets | £3,512,076 | £38,818,885 | +1,005.3% | |
| Equity | £3,512,076 | £38,818,885 | +1,005.3% | |
| Average employees | 20 | 94 | +370% | |
| Wages | £2,164,419 | £8,427,232 | +289.4% | |
| Directors' remuneration | £58,335 | £312,073 | +435% |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Return on capital employed | -236.3% | -71.0% | |
| Gearing (liabilities / total assets) | 32.1% | 19.9% | |
| Current ratio | 2.58x | 5.00x | |
| Interest cover | — | -4709.38x |
Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Margin ratios are hidden where reported turnover is too small relative to profit to yield a meaningful figure — typical of holding companies whose income is mostly subsidiary dividends rather than trading revenue. Sector-distribution context coming next.
Name history
Renamed 2 times since incorporation
- ASCEND ADVANCED THERAPIES LIMITED 2024-03-03 → present
- ASCEND GENE AND CELL THERAPIES LTD 2021-08-11 → 2024-03-03
- GCTX BASECAMP UK LTD 2021-06-22 → 2021-08-11
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Consolidated group
- Auditor
- Deloitte LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate. Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the group's and parent company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.”
Group structure
- ASCEND ADVANCED THERAPIES LIMITED · parent
- Ascend Advanced Therapies CA Inc 100%
- Ascend Advanced Therapies GmbH 100%
Significant events
- “On 1 April 2024, the Company acquired the manufacturing facility in Alachua, Florida, from Beacon Therapeutics Limited. In May 2024, second tranche of series A investment of $41 million has been received.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
1 active · 12 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| THORELL, Per Fredrik | Director | 2026-01-20 | Jul 1988 | Swedish |
Show 12 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| OAKWOOD CORPORATE SECRETARY LIMITED | Corporate Secretary | 2021-06-22 | 2026-01-22 |
| BEECHAM, Michael Charles | Director | 2023-02-07 | 2024-11-06 |
| COHEN, Fred | Director | 2021-12-29 | 2024-11-06 |
| FUNNELL, Timothy Michael, Dr | Director | 2021-06-22 | 2024-11-06 |
| KERN, Justin Wesley | Director | 2024-07-22 | 2024-11-06 |
| KOZLOV, Andrey | Director | 2023-03-20 | 2024-11-06 |
| MAY, Andrew Paul | Director | 2022-03-12 | 2023-02-15 |
| MCCONNELL III, Errett Wesley | Director | 2024-11-06 | 2025-06-03 |
| MURALIDHAR, Balaji | Director | 2023-02-07 | 2024-11-06 |
| SHIOZAKI, Eric Norio | Director | 2023-02-07 | 2024-07-22 |
| SINCLAIR, Andrew, Dr | Director | 2023-02-07 | 2024-11-06 |
| STELLA, Michael Anthony | Director | 2023-05-01 | 2026-01-20 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Charles Conn | Individual | Significant influence | 2021-12-29 | Ceased 2023-02-07 |
| Mr Fred Cohen | Individual | Significant influence | 2021-12-29 | Ceased 2023-02-07 |
| Dr Timothy Michael Funnell | Individual | Shares 25–50%, Voting 25–50%, Appoints directors | 2021-06-22 | Ceased 2021-12-29 |
| Monograph Capital Advisors (Uk) Llp | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2021-06-22 | Ceased 2021-08-09 |
Filing timeline
Last 20 of 125 total filings
Material constitutional events — rename, articles re-file, resolution
- 2024-11-26 RESOLUTIONS Resolution
- 2024-11-17 MA Memorandum articles
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-02-13 | AD01 | address | Change registered office address company with date old address new address | |
| 2026-02-10 | AP01 | officers | Appoint person director company with name date | |
| 2026-02-10 | TM01 | officers | Termination director company with name termination date | |
| 2026-01-29 | TM02 | officers | Termination secretary company with name termination date | |
| 2025-12-03 | DISS40 | gazette | Gazette filings brought up to date | |
| 2025-12-02 | GAZ1 | gazette | Gazette notice compulsory | |
| 2025-07-17 | TM01 | officers | Termination director company with name termination date | |
| 2025-06-30 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2024-11-26 | RESOLUTIONS | resolution | Resolution | |
| 2024-11-19 | TM01 | officers | Termination director company with name termination date | |
| 2024-11-19 | TM01 | officers | Termination director company with name termination date | |
| 2024-11-19 | TM01 | officers | Termination director company with name termination date | |
| 2024-11-19 | TM01 | officers | Termination director company with name termination date | |
| 2024-11-19 | TM01 | officers | Termination director company with name termination date | |
| 2024-11-19 | TM01 | officers | Termination director company with name termination date | |
| 2024-11-19 | TM01 | officers | Termination director company with name termination date | |
| 2024-11-19 | AP01 | officers | Appoint person director company with name date | |
| 2024-11-17 | MA | incorporation | Memorandum articles | |
| 2024-11-13 | SH06 | capital | Capital cancellation shares | |
| 2024-11-13 | SH03 | capital | Capital return purchase own shares |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 8
- Capital events
- 2
- Officers appointed
- 1
- Officers resigned
- 3
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.